Oral Administration of MB-102 Versus Dual Sugar Testing for Gut Permeability
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The objectives of the study are to evaluate the safety and tolerability of oral
administration of MB-102, and to evaluate the use of MB-102 as a means of measuring gut
permeability in normal participants (n=10) and in those with radiologic evidence of small
bowel Crohn's disease (n=10).